Lumexa Imaging shares rise 13.59% intraday after Raymond James upgrades stock to strong buy with $23 target.

Lumexa Imaging surged 13.59% intraday as Raymond James upgraded its stock to "Strong Buy" from "Outperform" with a $23 price target. The company offers diagnostic imaging services including MRI, CT scans, PET scans, X-rays, and ultrasounds, with revenue primarily from its outpatient imaging centers.